BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11984128)

  • 1. A review of epidemiological studies on cancer in relation to the use of anti-ulcer drugs.
    La Vecchia C; Tavani A
    Eur J Cancer Prev; 2002 Apr; 11(2):117-23. PubMed ID: 11984128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine-2-receptor antagonists and gastric cancer risk.
    La Vecchia C; Negri E; D'Avanzo B; Franceschi S
    Lancet; 1990 Aug; 336(8711):355-7. PubMed ID: 1975342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine-2 receptor antagonists and gastric cancer.
    Johnson AG; Jick SS; Perera DR; Jick H
    Epidemiology; 1996 Jul; 7(4):434-6. PubMed ID: 8793372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.
    Møller H; Nissen A; Mosbech J
    Gut; 1992 Sep; 33(9):1166-9. PubMed ID: 1358764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine-2-receptor antagonists and gastric cancer: update and note on latency and covariates.
    La Vecchia C; Negri E; Franceschi S; D'Avanzo B
    Nutrition; 1992; 8(3):177-81. PubMed ID: 1356031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
    Haga Y; Nakatsura T; Shibata Y; Sameshima H; Nakamura Y; Tanimura M; Ogawa M
    Dig Dis Sci; 1998 Feb; 43(2):253-7. PubMed ID: 9512115
    [No Abstract]   [Full Text] [Related]  

  • 10. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety issues relating to long-term treatment with histamine H2-receptor antagonists.
    Sabesin SM
    Aliment Pharmacol Ther; 1993; 7 Suppl 2():35-40. PubMed ID: 8103374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer occurrence in a cohort of patients treated with cimetidine.
    Møller H; Lindvig K; Klefter R; Mosbech J; Møller Jensen O
    Gut; 1989 Nov; 30(11):1558-62. PubMed ID: 2599442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant gastric ulcer: its natural history and outcome in the H2RA era.
    Raju GS; Bardhan KD; Royston C; Beresford J
    Am J Gastroenterol; 1999 Dec; 94(12):3478-86. PubMed ID: 10606307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
    Suleiman UL; Harrison M; Britton A; McPherson K; Bates T
    Eur J Cancer Prev; 2000 Jun; 9(3):185-91. PubMed ID: 10954258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].
    Andersen M; Schou JS
    Ugeskr Laeger; 1991 May; 153(20):1410-3. PubMed ID: 1674181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
    García Rodríguez LA; Lagergren J; Lindblad M
    Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists.
    Boero M; Pera A; Andriulli A; Ponti V; Canepa G; Palmas F; Duglio A; Molinaro GC; Toselli M; Riccardino N
    Digestion; 1983; 28(3):158-63. PubMed ID: 6141973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine-2-receptor antagonists and oesophageal cancer.
    Fioretti F; Tavani A; La Vecchia C; Franceschi S
    Eur J Cancer Prev; 1997 Apr; 6(2):143-6. PubMed ID: 9237063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.